Silence Therapeutics (SLN) Exchange Rate Effect (2024 - 2026)
Silence Therapeutics (SLN) reported Exchange Rate Effect of -$17000.0 for Q1 2026, down 107.33% on a YoY basis from $232000.0 in Q1 2025, and up 86.82% sequentially from -$129000.0 in Q4 2025.
Silence Therapeutics (SLN) Exchange Rate Effect (2024 - 2026) Analysis & Trends
Silence Therapeutics (SLN) has 3 years of Exchange Rate Effect data on file, last reported at -$17000.0 in Q1 2026.
- For the quarter ending Q1 2026, Exchange Rate Effect fell 107.33% year-over-year to -$17000.0; the trailing twelve-month figure through Mar 2026 stood at -$54000.0 (down 116.51% YoY), and the FY2025 full-year result was $195000.0, up 225.0% from the prior year.
- Exchange Rate Effect rose to -$17000.0 in Q1 2026, from -$129000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $268000.0 in Q3 2024 to a low of -$159000.0 in Q4 2024.
- A 3-year average of $26444.4 and a median of -$17000.0 in 2026 frame the typical range for Exchange Rate Effect.
- Peak annual rise in Exchange Rate Effect reached 1514.29% in 2025, while the deepest fall reached 139.55% in 2025.
- Tracing SLN's Exchange Rate Effect over 3 years: stood at -$159000.0 in 2024, then climbed by 18.87% to -$129000.0 in 2025, then jumped by 86.82% to -$17000.0 in 2026.
- Business Quant data shows SLN's Exchange Rate Effect at -$17000.0 in Q1 2026, -$129000.0 in Q4 2025, and -$106000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Silence Therapeutics | 1.62 Bn | 1.49 Bn | 411,000.00 | -17,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17,000.00 |
| Mar 31, 2026 | -17,000.00 |
| Dec 31, 2025 | -129,000.00 |
| Dec 31, 2025 | -129,000.00 |
| Sep 30, 2025 | -106,000.00 |
| Sep 30, 2025 | -106,000.00 |
| Jun 30, 2025 | 198,000.00 |
| Jun 30, 2025 | 198,000.00 |
| Mar 31, 2025 | 232,000.00 |
| Mar 31, 2025 | 232,000.00 |
| Dec 31, 2024 | -159,000.00 |
| Dec 31, 2024 | -159,000.00 |
| Sep 30, 2024 | 268,000.00 |
| Sep 30, 2024 | 268,000.00 |
| Jun 30, 2024 | -14,000.00 |
| Jun 30, 2024 | -14,000.00 |
| Mar 31, 2024 | -35,000.00 |
| Mar 31, 2024 | -35,000.00 |